Drug interactions
Linagliptin-metformin + Pioglitazone
Severity: Minor
Linagliptin-metformin and Pioglitazone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pioglitazone is combined with linagliptin and metformin in routine practice for additive glucose lowering, and pioglitazone is not a clinically significant CYP3A4 inhibitor. The combination mainly adds fluid retention and heart failure considerations from pioglitazone rather than a pharmacokinetic interaction.
What this interaction means in plain words
Linagliptin-metformin and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Linagliptin-metformin belongs to Endocrine; Pioglitazone belongs to Endocrine.
Why it happens
No meaningful pharmacokinetic interaction; effects are additive antihyperglycemic actions.
What to do
No dose adjustment is needed; monitor for edema, weight gain and heart failure symptoms with pioglitazone.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin-metformin and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Pioglitazone
Frequently asked questions
Can I take Linagliptin-metformin with Pioglitazone?
MediHelp rates the interaction as minor. Linagliptin-metformin and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pioglitazone is combined with linagliptin and metformin in routine practice for additive glucose lowering, and pioglitazone is not a clinically significant CYP3A4 inhibitor. The combination mainly adds fluid retention and heart failure considerations from pioglitazone rather than a pharmacokinetic interaction.
How serious is the interaction between Linagliptin-metformin and Pioglitazone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor for edema, weight gain and heart failure symptoms with pioglitazone.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
